Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1029 | 914 | 1029 | 1031 | 1228 | 1592 |
Fund Return | 2.92% | -8.62% | 2.92% | 1.03% | 4.19% | 4.76% |
Place in category | 538 | 590 | 538 | 254 | 352 | 245 |
% in Category | 78 | 84 | 78 | 45 | 61 | 64 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Great-West S&P 500 Index Init | 5.31B | 24.33 | 8.35 | 12.50 | ||
Great-West Moderate Profile II Init | 1.67B | 7.95 | 2.06 | 5.89 | ||
Great-West S&P 500 Index Instituti | 1.34B | 24.86 | 8.75 | - | ||
Great-West Conservative Profile II | 1.17B | 5.09 | 0.81 | 3.71 | ||
Great-West S&P Mid Cap 400 Index I | 1.14B | 13.27 | 4.27 | 9.06 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 201.2B | 5.09 | 0.61 | 5.00 | ||
Vanguard Total Intl Stock Index Adm | 72.9B | 5.14 | 0.67 | 5.06 | ||
Fidelity International Index Inst | 51.28B | 3.71 | 1.71 | 5.38 | ||
Fidelity Series Global ex US Index | 50.22B | 5.35 | 0.85 | 4.86 | ||
Strategic Advisers International I | 44.17B | 5.63 | 0.87 | 6.01 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 2.14 | 622.4 | +7.13% | |
United States Treasury Bills 0% | - | 1.91 | - | - | |
ASML Holding | NL0010273215 | 1.86 | 700.70 | -2.04% | |
Nestle | CH0038863350 | 1.47 | 74.68 | -0.03% | |
AstraZeneca | GB0009895292 | 1.35 | 11,050.0 | +0.04% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Strong Buy |
Technical Indicators | Strong Buy | Sell | BUY |
Summary | Strong Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review